Murine model of chronic L. (Viannia) panamensis infection: Role of IL‐13 in disease
Open Access
- 30 July 2010
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 40 (10), 2816-2829
- https://doi.org/10.1002/eji.201040384
Abstract
Leishmania (Viannia) organisms are the most prevalent etiologic agents of human cutaneous leishmaniasis in the Americas. Nevertheless, our knowledge of the immunological mechanisms exploited by L. (Viannia) organisms remains limited and the mechanisms underlying disease are not well understood. Here, we report the development of a BALB/c mouse model of L. (V.) panamensis infection that is able to reproduce chronic disease, with persistent infection and clinically evident lesions for over 1 year. The immune response of the mouse resembles that found for L. (V.) panamensis‐infected patients with chronic and recurrent lesions, presenting a mixed Th1/Th2 response with the presence of TNF‐α, IFN‐γ, IL‐10 and IL‐13. Using immunodeficient mice, the critical role for IL‐13 and/or IL‐4Rα in determining susceptibility to chronic infection was evident. With the induction of healing in the immunodeficient mice, increases in IFN‐γ and IL‐17 were found, concomitant with parasite control and elimination. Specifically, increases in CD4+ (but not CD8+) T cells producing IFN‐γ were observed. These results suggest that IL‐13 represents an important target for disease control of L. (V.) panamensis infection. This murine model should be useful to further understand the pathology associated with chronic disease and to develop methods for the treatment and prevention of leishmaniasis caused by L. (Viannia) parasites.Keywords
This publication has 72 references indexed in Scilit:
- Murine visceral leishmaniasis: IgM and polyclonal B‐cell activation lead to disease exacerbationEuropean Journal of Immunology, 2010
- Distinct Roles for MyD88 and Toll-Like Receptor 2 during Leishmania braziliensis Infection in MiceInfection and Immunity, 2009
- Interleukin 17 Production among Patients with American Cutaneous LeishmaniasisThe Journal of Infectious Diseases, 2009
- Immunological Determinants of Clinical Outcome in Peruvian Patients with Tegumentary Leishmaniasis Treated with Pentavalent AntimonialsInfection and Immunity, 2009
- IL-17 Promotes Progression of Cutaneous Leishmaniasis in Susceptible MiceThe Journal of Immunology, 2009
- Immunoregulatory mechanisms and CD4−CD8− (double negative) T cell subpopulations in human cutaneous leishmaniasis: A balancing act between protection and pathologyInternational Immunopharmacology, 2008
- Cytokines, Signaling Pathways, and Effector Molecules Required for the Control ofLeishmania(Viannia)braziliensisin MiceInfection and Immunity, 2007
- Deletion of IL-4Rα on CD4 T Cells Renders BALB/c Mice Resistant to Leishmania major InfectionPLoS Pathogens, 2007
- Antagonizing Deactivating Cytokines To Enhance Host Defense and Chemotherapy in Experimental Visceral LeishmaniasisInfection and Immunity, 2005
- Extracellular Amastigote‐Like Forms of Leishmania panamensis and L. braziliensis. II. Stage‐ and Species‐Specific Monoclonal AntibodiesThe Journal of Protozoology, 1989